Welcome to our dedicated page for WILLIS TOWERS WATSON PLC SEC filings (Ticker: WTW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on WILLIS TOWERS WATSON PLC's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into WILLIS TOWERS WATSON PLC's regulatory disclosures and financial reporting.
Willis Towers Watson (WTW) delivered a markedly more profitable Q2 2025 despite flat top-line growth. Revenue was $2.26 bn, virtually unchanged YoY, but disciplined cost control after the 2024 Transformation program lifted operating income 73% to $368 m and expanded the operating margin to 16.3% (vs 9.4%). Net income attributable to WTW more than doubled to $331 m, driving diluted EPS to $3.32 from $1.36. For the first six months, EPS rose 76% to $5.64 while revenue slipped 2.6% to $4.48 bn.
- Segment trends: Health, Wealth & Career revenue fell 6% but maintained a 23.9% operating margin; Risk & Broking rose 7.5% with margin up to 21.2%.
- Balance sheet: Cash increased to $1.96 bn; long-term debt cut 10% to $4.76 bn, lowering leverage. AOCL improved by $452 m.
- Capital returns: Company repurchased $700 m of shares in H1, shrinking share count to 97.9 m; dividends paid totaled $179 m.
- Cash flow: Operating cash flow fell 24% to $326 m; a $836 m divestiture boosted investing inflows, while heavy buybacks drove a $800 m financing outflow.
- Guidance & outlook: Management highlights continued margin expansion post-transformation but notes macro, FX and regulatory risks within the 10-Q.